% | $
Quotes you view appear here for quick access.

Zynga, Inc. Message Board

stamas5 3 posts  |  Last Activity: Apr 24, 2015 1:41 PM Member since: Jan 24, 2007
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • stamas5 stamas5 Apr 24, 2015 1:41 PM Flag

    Nearly 30 percent of the world’s population is either obese or overweight

  • Andrea Leone-Bay
    Vice President Scientific Research
    Obesity is a rapidly becoming a global epidemic and underlies many disease conditions including diabetes and cardiovascular disease. Current treatment options are limited and are challenged by undesirable side effects. Oxyntomodulin (OXY) is an endogenous peptide hormone that signals satiety in healthy individuals. High circulating OXY concentrations are associated with satiety and low OXY concentrations are associated with a feeling of hunger. This activity profile positions OXY as a potential treatment for obesity. To address this unmet medical need, this presentation will introduce an approach to developing an orally inhaled dry powder OXY product administered using a small, breath-powered inhaler for obesity therapy.

    The audience will learn about oxyntomodulin, a potential new obesity therapy and about the administration of peptides by oral inhalation using a simple, patient-friendly approach.

  • I went with my father for his office visit (new patient-not diabetic) and asked the Doctor at the end of the visit if he has prescribed any Afreeza with his response - 2 patients that are very happy with the results. When I go back in 3 weeks I will ask if they were samples or scrips and how they liked the Sanofi's rep presentation and I will ask about lung testing. This doctor has a general practice and is a Endo

2.52-0.01(-0.40%)Apr 24 4:00 PMEDT